Find a Physician
Decrease (-) Restore Default Increase (+)

Diabetes and nerve damage
Diabetes and nerve damage

Central nervous system
Central nervous system


Diabetic neuropathy is a common complication of diabetes , in which nerves are damaged as a result of high blood sugar levels (hyperglycemia).

Alternative Names:

Nerve damage - diabetic

Causes, incidence, and risk factors:

People with diabetes commonly develop temporary or permanent damage to nerve tissue. Nerve injuries are caused by decreased blood flow and high blood sugar levels , and are more likely to develop if blood sugar levels are not well controlled.

Some people with diabetes will not develop nerve damage, while others may develop this condition early. On average, symptoms begin 10 to 20 years after the diabetes diagnosis. Approximately 50% of people with diabetes will eventually develop nerve damage.

Peripheral nerve injuries may affect nerves in the skull (cranial nerves) or nerves from the spinal column and their branches. This type of nerve injury (neuropathy) tends to develop in stages.

Autonomic neuropathies affect the nerves that regulate vital functions, including the heart muscle and smooth muscles.


Digestive tract:

Legs and arms:

  • Deep pain, most commonly in the feet and legs
  • Loss of the sense of warm or cold
  • Muscle cramps
  • Numbness (if the nerves are severely damaged, you may be unaware that a blister or minor wound has become infected)
  • Tingling or burning sensation in the extremities, particularly the feet
  • Weakness

Other symptoms:

Note: Symptoms vary depending on the nerves affected, and may include symptoms other than those listed. Symptoms usually develop gradually over years.

Signs and tests:

Physical examination , including nervous system (neurological) and sensory tests, may diagnose neuropathies. A common early finding is the absence of ankle reflexes.

Health care providers often test for loss of sensation in the feet with a brush-like instrument called a monofilament.

Electrodiagnostic testing may be done.


The goals of treating diabetic neuropathy are to prevent the disease from getting worse and to reduce the symptoms of the disease.

Tight control of blood sugar (glucose) is important to prevent symptoms and problems from getting worse.

Medications may be used to reduce the symptoms in the feet, legs, and arms. These medications include:

  • Antidepressant drugs, such as amitriptyline (Elavil), doxepin (Sinequan), or duloxetine (Cymbalta)
  • Antiseizure medications, such as gabapentin (Neurontin), pregabalin (Lyrica), carbamazepine (Tegretol), and valproate (Depakote)
  • Drugs that block bladder contractions may be used to help with urinary control problems.
  • Erythromycin, domperidone (Motilium), or metoclopramide (Reglan) may help with nausea and vomiting.
  • Pain medications (analgesics) may work for some patients on a short-term basis, but in most cases they do not provide much benefit.
  • Phosphodiesterase type 5 (PDE-5) drugs, such as sildenafil (Viagra), vardenafil (Levitra), and tadalafil (Cialis) are safe and effective for treating impotence in patients with diabetes.
  • Capsaicin can be used topically to reduce pain.

Regular foot exams are important to identify small infections and prevent foot injuries from getting worse. If foot injuries go unnoticed for too long, amputation may be required.

Support Groups:

Expectations (prognosis):

Treatment relieves pain and can control some symptoms, but the disease generally continues to get worse.

  • Injury to the feet due to loss of feeling
  • Muscle breakdown and imbalance
  • Poor blood sugar control due to nausea and vomiting
  • Skin and soft tissue breakdown (ulceration) that may require amputation

In addition, neuropathy may mask angina , the warning chest pain for heart disease and heart attack.

Calling your health care provider:

Call your health care provider if you develop symptoms of diabetic neuropathy.


Tight control of blood sugar levels may prevent neuropathy in many people with type 1 diabetes, and may reduce the severity of symptoms.

In addition, regular foot care can prevent a small infection from getting worse. This is why no appointment for diabetes care is complete without a thorough foot examination.


Vinik AI. Diabetic neuropathies. Med Clin North Am. 2004;88(4):947-999.

Vardi M, Nini A. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. Cochrane Database Syst Rev. 2007;(1):CD002187.

Wong MC, Chung JW, Wong TK. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ. 2007;335:87.

American Diabetes Association (ADA). Standards of medical care in diabetes--2008. Diabetes Care. 2008;31:S12-S54.

Review Date: 8/20/2008
Reviewed By: A.D.A.M. Editorial Team: David Zieve, MD, MHA, Greg Juhn, MTPW, David R. Eltz. Previously reviewed by Elizabeth H. Holt, MD, PhD, Assistant Professor of Medicine, Section of Endocrinology and Metabolism, Yale University. Review provided by VeriMed Healthcare Network (3/18/2008).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

About Us

Emanuel Cancer Centers 2013 Annual Report
Joint Notice of Privacy Practices
Accreditation & Quality Measures
Board of Directors
CEO's Message
Community Crisis Information
Maps & Directions
Mission & Ministry
News & Publications

Care & Services

Emanuel Physician Finder

Employees & Physicians

e-MC Physician Portal
Web Mail
Employment Services
Physician Verification
Living in Turlock
Contact Us

Emanuel Medical Center
825 Delbon Avenue
Turlock, CA 95382
(209) 667-4200
Contact Us
© 2015 Emanuel Medical Center, Inc. All rights reserved
Home   |   Site Map   |   Joint Notice of Privacy Practices